Adrenocortical carcinoma · NCT07072143
PARTNER: An International Study on Pediatric Patients With Rare Tumors.
The PARTNER Study - An International Prospective Observational Study on Pediatric Patients With Very Rare Tumors.
- Status
- RECRUITING (ClinicalTrials.gov)
- Phase
- observational
- Sponsor
- Azienda Ospedaliera di Padova
- Registry records
- CTGOV NCT07072143 (RECRUITING)Registry last updated 2025-07-18
Eligibility, line by line
| Verdict | In plain words (machine summary) | Registry text, verbatim | If unmet |
|---|---|---|---|
| inclusion inclusion · age sex · confidence 0.97 | Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and/or treated in a participating country/center. | "Children and adolescents (age 0-18 years)" | |
| inclusion inclusion · condition · confidence 0.95 | Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and/or treated in a participating country/center. | "primary or relapsed Very Rare Tumor" | |
| inclusion inclusion · logistics · confidence 0.30 | Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and/or treated in a participating country/center. | "diagnosed and/or treated in a participating country/center" | |
| inclusion inclusion · consent · confidence 0.30 | Written informed consent from the patient and/or the parent/legal guardian | "Written informed consent from the patient and/or the parent/legal guardian" | |
| exclusion exclusion · consent · confidence 0.30 | Absence of Written informed consent from the patient and/or the parent/legal guardian | "Absence of Written informed consent from the patient and/or the parent/legal guardian" |
Criteria extracted by claude-sonnet-5-5; 0 extracted quotes rejected for not matching the registry text.
Full eligibility text as the registry publishes it
Inclusion Criteria: * Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and/or treated in a participating country/center. * Written informed consent from the patient and/or the parent/legal guardian Exclusion Criteria: * Absence of Written informed consent from the patient and/or the parent/legal guardian
Routes in: how this trial is reached and paid for
Free patient navigation
myTomorrows (Amsterdam) provides medically trained, multilingual patient navigators who search ClinicalTrials.gov, EU CTIS and ISRCTN and can support a doctor through an expanded-access application. Free to patients and families.
A navigator keeps searching after any single page stops being current. Use it alongside this site, not instead of your oncologist.
Verify with: myTomorrows for patients
0
Sites (1)
Italy
- Pediatric Oncology Unit, University Hospital Padova [AOUP Azienda Ospedale Università Padova], Padova